封面
市場調查報告書
商品編碼
1611167

肌腱炎治療的全球市場規模、佔有率和趨勢分析報告:按治療、症狀、地區和細分市場進行預測(2025-2030)

Tendonitis Treatment Market Size, Share & Trends Analysis Report By Treatment, By Condition, By Region, And Segment Forecasts, 2025 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

肌腱炎治療市場的成長與趨勢:

根據Grand View Research, Inc.最新報告,預計2030年全球肌腱炎治療市場規模將達2,818億美元,2025年至2030年複合年成長率為3.1%。

身體活動和體育活動參與的增加對運動相關傷害發生率的增加有直接影響。此外,預計工業事故發生率的上升將有助於預測期內該行業的發展和成長。世界上不斷成長的老年人口也更容易患骨病、糖尿病、關節炎、骨關節炎、骨質疏鬆症或肌腱炎。不斷創新先進的治療方法和技術來管理肌腱炎的市場參與企業也為市場的成長做出了貢獻。

投資增加、產業聯盟和政府支持加強也是加速市場成長的主要因素。在過去的幾年裡,運動員的醫療保健已經從積極治療方法,治療方法防止受傷。根據標準兒童健康的數據,2018年,美國參與體育活動的3,000萬青少年中,約有350萬人遭受了與運動相關的傷害。根據研究,美國每年約有775,000名青少年接受運動相關傷害的治療或治療。

在 COVID-19 大流行期間以及各國實施封鎖和旅行限制期間,由於肌腱炎治療數量的減少,行業成長受到了負面影響。體育賽事的延後和取消導致運動相關傷害發生率下降,導致市場表現下滑。 2021年,治療領域佔最大佔有率,預計在預測期內將大幅成長。這是因為非侵入性治療方法是首選。治療管理的第一線是物理治療,預計將顯著成長。

跟腱炎細分市場在 2022 年佔據產業主導地位。這種成長是由於運動員中與運動相關的傷害發生率增加所致。根據研究,跟腱炎的發生率為每10萬人中5至10人。由於知名製造商和分銷商的存在、運動相關傷害和創傷發生率的增加以及人們對各種療法和外科手術的可用性的認知不斷增強,北美在 2022 年佔據了最大佔有率。

肌腱炎治療市場報告亮點

  • 按治療方式來看,治療細分市場在 2024 年佔據了最大的收益佔有率,並在肌腱炎治療行業中佔據主導地位。肌腱炎患者對非侵入性治療的日益偏好促進了這一領域的成長。
  • 按症狀分類,跟腱炎細分市場佔據主導地位,2024 年銷售佔有率為 48.8%。由於跟腱炎的高發病率,尤其是運動員和從事重複性體力活動的人,該細分市場佔據了市場主導地位。
  • 北美肌腱炎治療市場佔據主導地位,2024 年收益佔有率為 42.2%。該地區肌腱炎手術數量的增加和消費者可支配收入水準的上升對該地區的成長做出了貢獻。
  • 由於人口迅速老化、肌肉骨骼健康意識不斷增強以及醫療保健投資不斷增加等綜合因素,預計亞太地區在預測期內將見證肌腱炎治療市場的最快成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章肌腱炎治療市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 配套市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 法律規範
  • 肌腱炎治療:市場分析工具
    • 產業分析:波特五力分析
    • PESTLE分析

第4章肌腱炎治療細分市場分析:依治療類型(2018-2030)

  • 定義和範圍
  • 治療市場佔有率分析(2024/2030)
  • 細分儀表板
  • 全球肌腱炎治療市場:依治療分類(2018-2030)
  • 治療
    • 治療市場估計與預測(2018-2030)
    • 熱療和冷療
    • 物理治療
    • 衝擊波療法
  • 外科手術
    • 手術市場估計與預測(2018-2030)

第5章肌腱炎治療細分市場分析:依症狀(2018-2030)

  • 定義和範圍
  • 症狀市場佔有率分析(2024/2030)
  • 細分儀表板
  • 全球肌腱炎治療市場:依症狀分類(2018-2030)
  • 網球肘
    • 網球肘的市場估計與預測(2018-2030)
  • 高爾夫球肘
    • 高爾夫球肘的市場估計與預測(2018-2030)
  • 棒球肘
    • 棒球肘市場估計與預測(2018-2030)
  • 跳膝
    • 跳繩膝蓋市場估計與預測(2018-2030)
  • 游泳肩膀
    • 游泳肩市場估計與預測(2018-2030)
  • 跟腱炎
    • 跟腱炎市場估計與預測(2018-2030)

第6章肌腱炎治療細分市場分析:按地區(2018-2030)

  • 區域市場佔有率分析(2024/2030)
  • 區域市場儀表板
  • 區域市場簡介
  • 肌腱炎治療市場佔有率:按地區(2024/2030)
  • 北美洲
    • 北美肌腱炎治療市場(2018-2030)
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲肌腱炎治療市場(2018-2030)
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 公司簡介
    • Merck and Co., Inc.
    • Bayer AG
    • AstraZeneca
    • Boehringer Ingelheim Pharmaceuticals, Inc.
    • Abbott
    • Pfizer
    • GlaxoSmithKline PLC
    • Almatica Pharma, Inc.
    • Teva Pharmaceuticals Industries
Product Code: GVR-4-68039-530-4

Tendonitis Treatment Market Growth & Trends:

The global tendonitis treatment market size is expected to reach USD 281.8 billion by 2030, registering a CAGR of 3.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing participation in physical and sporting activities, directly influences the rise in prevalence of sports-related injuries. In addition, the rising incidence of occupational injuries is anticipated to contribute to the development and growth of the industry over the forecast period. The growing global geriatric population is susceptible to bone disorders, diabetes, arthritis, osteoarthritis, osteoporosis, or tendonitis. Industry participants that are constantly innovating advanced therapies and technologies in managing tendonitis are also contributing to the market growth.

Growing investments, industry collaborations, and increasing favorable government support are other key factors accelerating market growth. Over the past years, there has been a transition from proactive to preventive therapies in managing the health of sportspersons in preventing injuries. According to Standard Children's Health, in 2018, approximately 3.5 million out of 30 million adolescents participating in sporting activities in the U.S. incur sports-related injuries. As per studies, annually, around 775,000 adolescents receive therapies and treatments for sports-related injuries in the U.S. Major players are expanding their business footprint in both developed and emerging economies through product innovation and strengthening their distribution cycles.

During the COVID-19 pandemic and enforced lockdowns and travel restrictions imposed across countries, the industry growth was negatively impacted owing to a decline in the number of tendonitis treatment procedures. Postponement and cancellation of sporting events led to a decline in the incidence of sports-related injuries, thereby, resulting in a decline in the business performance of the market. In 2021, the therapy segment accounted for the largest share and is anticipated to grow significantly over the forecast period. This is owing to the high preference for non-invasive treatment procedures. The first line of treatment management is physical therapy, which is expected to witness considerable growth.

The Achilles tendonitis segment dominated the industry in 2022. This growth can be attributed to the growing incidence of sports-related injuries in sports players. As per studies, the incidence rate of Achilles tendonitis ranges between 5 to 10 individuals per 100,000 people. North America accounted for the largest share in 2022 owing to the presence of renowned manufacturers and distributors, growing incidence of sports-related & trauma injuries, and rising awareness about the availability of various therapies & surgical procedures.

Tendonitis Treatment Market Report Highlights:

  • By treatment, the therapy segment dominated the tendonitis treatment industry with the largest revenue share in 2024. The increasing preference of patients with tendonitis for non-invasive treatments contributes to segment growth.
  • By condition, the Achilles tendonitis segment dominated the market with a revenue share of 48.8% in 2024. The segment dominated the market due to the high incidence of Achilles tendonitis condition, particularly among athletes and individuals engaged in repetitive physical activities.
  • North America tendonitis treatment market dominated with a revenue share of 42.2% in 2024. A growing number of surgeries performed for tendonitis in the region and increasing consumer disposable income levels are among the few factors that contribute to the region's growth.
  • The Asia Pacific region is expected to witness the fastest growth in the tendonitis treatment market over the forecast period, driven by a combination of factors such as a large and rapidly aging population, increased awareness about musculoskeletal health, and rising healthcare investments.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Condition outlook
    • 2.2.2. Treatment outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Tendonitis Treatment Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Regulatory Framework
  • 3.4. Tendonitis Treatment: Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
    • 3.4.2. PESTLE Analysis

Chapter 4. Tendonitis Treatment Market Segment Analysis, By Treatment, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Treatment Market Share Analysis, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Tendonitis Treatment Market, by Treatment, 2018 to 2030
  • 4.5. Therapy
    • 4.5.1. Therapy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. Hot and Cold Therapy
      • 4.5.2.1. Hot and Cold Therapy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Physical Therapy
      • 4.5.3.1. Physical therapy market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.4. Shockwave Therapy
      • 4.5.4.1. Shockwave Therapy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Surgery
    • 4.6.1. Surgery market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Tendonitis Treatment Market Segment Analysis, By Condition, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Condition Market Share Analysis, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Tendonitis Treatment Market, by Condition, 2018 to 2030
  • 5.5. Tennis elbow
    • 5.5.1. Tennis elbow market estimates and forecasts, 2018 to 2030 (USD million)
  • 5.6. Golfer's elbow
    • 5.6.1. Golfer's elbow market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Pitcher's elbow
    • 5.7.1. Pitcher's elbow market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Jumper's Knee
    • 5.8.1. Jumper's Knee market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Swimmer's shoulder
    • 5.9.1. Swimmer's shoulder market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.10. Achilles Tendonitis
    • 5.10.1. Achilles tendonitis market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Tendonitis Treatment Market Segment Analysis, By Region, 2018- 2030 (USD Million)

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Tendonitis Treatment Market Share by Region, 2024 & 2030:
  • 6.5. North America
    • 6.5.1. North America tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. U.S. tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Canada tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Mexico tendonitis treatment market, 2018 - 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. UK tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Germany tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. France tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Italy tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Spain tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.7. Norway
      • 6.6.7.1. Norway tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Sweden tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.6.9. Denmark
      • 6.6.9.1. Denmark tendonitis treatment market, 2018 - 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Japan tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. China tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. India tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Australia tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. South Korea tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Thailand tendonitis treatment market, 2018 - 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Brazil tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Argentina tendonitis treatment market, 2018 - 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. South Africa tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Saudi Arabia tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. UAE tendonitis treatment market, 2018 - 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Kuwait tendonitis treatment market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Profiles
    • 7.3.1. Merck and Co., Inc.
      • 7.3.1.1. Company overview
      • 7.3.1.2. Financial performance
      • 7.3.1.3. Product benchmarking
      • 7.3.1.4. Strategic initiatives
    • 7.3.2. Bayer AG
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. AstraZeneca
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. Boehringer Ingelheim Pharmaceuticals, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Abbott
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Pfizer
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. GlaxoSmithKline PLC
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Almatica Pharma, Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Teva Pharmaceuticals Industries
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. Product pipeline/clinical stage
  • Table 4. List of emerging companies in tendonitis treatment market
  • Table 5. North America Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 6. North America Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 7. North America Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 8. U.S. Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 9. U.S. Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 10. Canada Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 11. Canada Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 12. Mexico Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 13. Mexico Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 14. Europe Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 15. Europe Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 16. Europe Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 17. U.K. Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 18. U.K. Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 19. Germany Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 20. Germany Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 21. France Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 22. France Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 23. Spain Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 24. Spain Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 25. Italy Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 26. Italy Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 27. Norway Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 28. Norway Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 29. Denmark Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 30. Denmark Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 31. Sweden Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 32. Sweden Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 36. China Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 37. China Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 38. Japan Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 39. Japan Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 40. India Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 41. India Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 42. Australia Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 43. Australia Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 44. South Korea Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 45. South Korea Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 46. Thailand Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 47. Thailand Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 48. Latin America Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 49. Latin America Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 50. Latin America Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million
  • Table 51. Brazil Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 52. Brazil Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 53. Argentina Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 54. Argentina Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 55. MEA Tendonitis Treatment market, by country, 2018 - 2030 (USD Million)
  • Table 56. MEA Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 57. MEA Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 58. South Africa Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 59. South Africa Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 60. Saudi Arabia Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 62. UAE Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 63. UAE Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)
  • Table 64. Kuwait Tendonitis Treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 65. Kuwait Tendonitis Treatment market, by condition, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Volume Price Analysis
  • Fig. 10 Tendonitis Treatment Market snapshot (2022)
  • Fig. 11 Tendonitis Treatment Market segmentation
  • Fig. 12 Market trends and outlook
  • Fig. 13 Parent market outlook
  • Fig. 14 Related/ancillary market outlook
  • Fig. 15 Market driver relevance analysis (Current & future impact)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Tendonitis Treatment Market, treatment outlook: key takeaways (USD Million)
  • Fig. 18 Tendonitis Treatment Market: treatment movement analysis, 2022 & 2030 (USD Million)
  • Fig. 19 Therapy Treatment Market 2018 - 2030 (USD Million)
  • Fig. 20 Hot and Cold Treatment Market 2018 - 2030 (USD Million)
  • Fig. 21 Physical Therapy Treatment Market 2018 - 2030 (USD Million)
  • Fig. 22 Shockwave Therapy Treatment Market 2018 - 2030 (USD Million)
  • Fig. 23 Surgery Treatment Market 2018 - 2030 (USD Million)
  • Fig. 24 Tendonitis Treatment Market, Condition outlook: key takeaways (USD Million)
  • Fig. 25 Tendonitis Treatment Market: Condition movement analysis, 2022 & 2030 (USD Million)
  • Fig. 26 Tennis Elbow market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Golfer's Elbow market estimates and forecasts, 2018 - 2030 (USD Million
  • Fig. 28 Pitcher's Elbow market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Jumper's Knee market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Swimmer's Shoulder market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Achilles Tendonitis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Tendonitis Treatment Market, regional marketplace: Key takeaways (USD Million)
  • Fig. 33 Tendonitis Treatment Market: regional movement analysis, 2022 & 2030 (USD Million)
  • Fig. 34 North America Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Mexico Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Germany Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 U.K. Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Norway Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Japan Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 China Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Thailand Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 MEA Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Africa Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Saudi Arabia Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait Tendonitis Treatment Market estimates and forecasts, 2018 - 2030 (USD Million)